Status:
COMPLETED
MK0954A-264 Filter Study (0954A-264)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Mild to Severe Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To compare the blood pressure lowering efficacy, safety and tolerability of a combination drug to a single drug taken once daily in patients with uncontrolled blood pressure following a 4-week filter ...
Eligibility Criteria
Inclusion
- Male and female patients with mild to severe hypertension (SiDBP 90-120 mmHg)
Exclusion
- Systolic BP \> 200 mmHg
- Secondary or malignant hypertension
- Taking more than 2 antihypertensive medications
- Hypertension induced by oral contraceptives
- Hx of cerebral vascular accident within 6 months
- Hx of angina, myocardial infarction, PCI, CABG, or decompensated CHF within 6 months
- Clinically significant AV conduction disturbance or potentially life threatening ventricular arrhythmias, valvular disease, cardiomyopathy, unexplained syncope
- History of angioedema
- Sensitivity to AII receptor antagonists or HCTZ, nephrotic syndrome,single kidney function
- Pregnancy or lactation.
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 2 2005
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT00307060
Start Date
December 1 2004
End Date
June 2 2005
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.